• OPEN AN ACCOUNT
Indian Indices
Sensex
76,933.59 -539.35
( -0.70%)
Global Indices
Nasdaq
53,487.87 -110.53
(-0.21%)
Dow Jones
7,697.38 -0.90
(-0.01%)
Hang Seng
66,058.92 -203.24
(-0.31%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.31 -0.39
(-0.41%)
EUR-INR
111.19 -0.48
(-0.43%)
GBP-INR
129.97 -0.53
(-0.40%)
JPY-INR
0.60 0.00
(-0.54%)

EQUITY - MARKET SCREENER

Raw Edge Industrial Solutions Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
541634
INE960Z01014
20.742464
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
40.64
15.94
EPS(TTM)
Face Value()
Div & Yield %
0.39
10
0
 

pakka ltd
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12